About
Novel oncology therapeutics
Areas of Focus
Categories
Biotech
Team (26)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
257
By Phase
PHASE1: 3PHASE1/PHASE2: 2
By Status
TERMINATED: 2COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06433947Lead Sponsor
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
PHASE1Recruiting
130 participants
Started: Aug 22, 2024 · Completed: Jul 31, 2026
NCT04556617Lead Sponsor
PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
PHASE1/PHASE2Terminated
19 participants
Started: Sep 21, 2020 · Completed: May 24, 2022
NCT04493619Lead Sponsor
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
PHASE1/PHASE2Terminated
37 participants
Started: Aug 11, 2020 · Completed: Apr 25, 2022
NCT03787498Lead Sponsor
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
PHASE1Completed
22 participants
Started: Mar 19, 2019 · Completed: Jun 30, 2021
NCT03297424Lead Sponsor
A Study of PLX2853 in Advanced Malignancies.
PHASE1Completed
49 participants
Started: Sep 12, 2017 · Completed: Jun 7, 2021
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...